Abstract:
Hepatitis B virus (HBV) is one of the major etiological agents responsible for the appearance of chronic liver diseases, including hepatocellular carcinoma (HCC). There is increasing evidence that the HBV excoded x antigen (HBxAg) is involved in one or more steps that contribute to multistep hepatocarcinogenesis. Recent work has now defined one of these steps as the physical binding and functional inactivation of the tumor suppressor protein, p53, by HBxAg. The centrality of p53 to genomic stability, cell cycle arrest, induction of apoptosis, and in senescence related pathways, suggests that its disruption by HBxAg will result in genomic instability, loss of cell cycle control, a lower apoptotic rate, and an extension in the life span of HBV-infected cells. It is proposed that HBxAg/p53 complex formation represents one of several steps whereby HBV contributes to the development of HCC.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received for publication on Jan. 6, 1998; accepted on June 10, 1998
About this article
Cite this article
Feitelson, M. Hepatitis B x antigen and p53 in the development of hepatocellular carcinoma. J Hep Bil Pancr Surg 5, 367–374 (1998). https://doi.org/10.1007/s005340050060
Issue Date:
DOI: https://doi.org/10.1007/s005340050060